List of Immunotherapy Concept Stocks Leaders

Do you know the concept of immunotherapy stocks? Do you know what are the main immunotherapy concept stock leaders? Today, the financial gentleman will take you to understand together. The following is a list of leading immunotherapy stocks.

Friday (December 15), immunotherapy concept stocks soared, as of the close of business, immunotherapy concept stocks leading Beilu Pharmaceuticals, and the good shares, Zuo Li Pharmaceuticals sealed a halt, Yaoji Poker, Guanhao Biological, Kangtai Biological and other leading.

Leading immunotherapy concept stocks:

A few days ago, Nanjing Legend Bio LCAR-B38MCAR-T cell preparation registration filing was accepted by the CDE, becoming the first registered CAR-T therapy.

Dongfang Securities believes that the domestic CAR-T therapy into the registration and declaration stage, clinical application further. It is recommended to pay attention to the domestic immune cell therapy layout of the more leading companies, such as Anke Bio, Fosun Pharmaceuticals, Hengrui Pharmaceuticals.

IFCS maintains the industry "hold" rating, cell therapy-related attention to the combination of: Kingsley Biotechnology 1548HK (Nanjing Legend), WuXi Biotechnology 2269.HK (WuXi JUNO), Fosun Pharmaceuticals 600196.SH (Fosun Kite), Zoli Pharmaceuticals 300181.SZ (Keji Bio), Ankor Bio, Fosun Pharma 600196.SH (Fosun Kite), Zoli Pharma 300181.SZ (Keji Bio), Ankor Bio, Ankor Bio. (SZ (Keji Bio), Anke Bio 300009.SZ (Anke Bosengi).

Beilu Pharmaceuticals main business: drug production as well as drug distribution.

Hejia's main business: the main business is to provide intelligent medical overall solutions, mainly including the overall construction of hospitals, medical services, medical information, medical equipment production and sales and other business segments.

Zoli Pharmaceuticals main business: research and development, production and sales of medicinal fungi products.